Rare aggressive natural killer cell leukemia presented with bone marrow fibrosis - a diagnostic challenge

SpringerPlus

Volumn 3, Issue 1, 2014, Pages 1-9

  Soliman, Dina S ^a   Sabbagh, Ahmad Al ^a   Omri, Halima El ^a   Ibrahim, Firyal A ^a   Amer, Aliaa M ^a   Otazu, Ivone B ^a  

^a HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

Aggressive natural killer cell leukemia; Bone marrow fibrosis; Dysmegakaryopoiesis

Indexed keywords

EID: 84940315201     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-3-390     Document Type: Article

References (29)

1. Fernandez LA, Pope B, Lee C, Zayed E: Aggressive natural killer cell leukemia in an adult and establishment of an NK cell line. Blood 1986, 67: 925-930.
2. Imamura N, Kusunoki Y, Kawa-Ha K, Yunuma K, Hara J, Oda K, Abe K, Dohy H, Inada T, Kajihara H, Kuramoto A: Aggressive natural killer cell leukemia/lymphoma: Report of four cases and review of the literature. Br J Haematol 1990, 75: 49-59. 10. 1111/j. 1365-2141. 1990. tb02615. x.
3. Chan JKC, Wong KF, Jaffe ES, Ralfkiaer E: "Aggressive NK-Cell Leukemia". In World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues. Edited by: Jaffe ES, Harris NL, Stein H, Vardiman JW. France: World Health Organization Classification of Tumours. 2001 IARC Press Lyon; 2001. 204-207.
4. Chan JK, Quintanilla-Martinez L, Ferry JA, Peh SC, et al.: Extranodal NK/T-cell lymphoma, nasal type. In WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Edited by: Swerdlow SH, Campo E, Harris NL. Lyon: IARC; 2008: 285-288.
5. Chan JK: Natural killer cell neoplasms. Anat Pathol 1998, 3: 77-145.
6. Chan WK, Au WY, Wong CY, Liang R, Leung AY, Kwong YL, Khong P: Metabolic activity measured by F-18 FDG PET in natural killer-cell lymphoma compared to aggressive B- and T-cell lymphomas. Clin Nucl Med 2010, 35(8): 571-575. 10. 1097/RLU. 0b013e3181e4dcbf.
7. Jiang N-g, Jin Y-m, Niu Q, Zeng T-t, Jun S, Zhu H-l: Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood. Ann Hematol 2013, 92: 89-96. 10. 1007/s00277-012-1574-3.
8. Trotta R, Parihar R, Yu J, Becknell B, Allard J 2nd, Wen J, Ding W, Mao H, Tridandapani S, Carson WE, Caligiuri MA: Differential expression of SHIP in CD56 bright and CD56 dim NK cells provides a molecular basis for distinct functional responses to monokine co-stimulation. Blood 2005, 105(8): 3011-3018. 10. 1182/blood-2004-10-4072.
9. Nava VE, Jaffe ES: The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol 2005, 12: 27-34. 10. 1097/01. pap. 0000151318. 34752. 80.
10. Kwong YL, Chan AC, Liang R, Chiang AK, Chim CS, Chan TK, Todd D, Ho FC: CD56+ NK lymphoma. Clinicopathological features and prognosis. Br J Haematol 1997, 97(4): 821-829. 10. 1046/j. 1365-2141. 1997. 1462962. x.
11. Shaffer L, Slovak M, Cambell L (Eds): In ISCN An International System for Human Cytogenetic Nomenclature Basel, S. Karger. 2009.
12. Sokol L, Loughran TP Jr: Large Granular Lymphocytic Leukaemia. Oncologist 2006, 11: 263-273. 10. 1634/theoncologist. 11-3-263.
13. Gogia A, Kakar A, Byotra SP, Bhargava M: Aggressive natural killer cell leukaemia: a rare and fatal disorder. J Assoc Physicians India 2010, 58: 702-4.
14. Ryder J, Wang X, Bao L, Gross SA, Hua F, Iron RD: Aggressive natural killer cell leukemia; a report of a Chinese series and review of the literature. Leuk Lymphoma 2007, 45: 2427-2438.
15. Zhang H, Meng Q, Yin W, Xu L, Lie L: Adult Aggressive Natural Killer Cell Leukemia. Am J Med Sci 2012, 0(0): 1-8.
16. Okuno Y, Tatetsu H, Nosaka K, Mitsuya H: Three cases of aggressive natural killer cell leukemia with a lethal hemorrhagic complication. J Clin Exp Hematopathol 2012, 52(2): 101-6. 10. 3960/jslrt. 52. 101.
17. Boysen AK, Jensen P, Johansen P, Dybkær K, Nyegaard M: Treatment of Aggressive NK-Cell Leukemia-A Case Report and Review of the Literature. Case Reports Hematology 2011, 2011: 818469.
18. Chan JKC, Sin VC, Wong KF: Non nasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997, 89: 4501-4513.
19. Au WY, Pang A, Choy C, Chim CS, Kwong YL: Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 2004, 104(1): 243-249. 10. 1182/blood-2003-12-4197.
20. Eric T, Yok-Lam K: How I treat NK/T-cell lymphomas. Blood 2013, 121(25): 4997-5005. 10. 1182/blood-2013-01-453233.
21. Suzuki R, Suzumiya J, Nakamura S, Aoki S, Notoya A, Ozaki S, Gondo H, Hino N, Mori H, Sugimori H, Kawa K, Oshimi K: Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 2004, 18: 763-770. 10. 1038/sj. leu. 2403262.
22. Ruskova A, Thula R, Chan G: Aggressive natural killer leukemia: report of five cases and review of the literature. Leuk Lymphoma 2004, 45(12): 2427-2438. 10. 1080/10428190400004513.
23. Nakashima Y, Tagawa H, Suzuki R, Karnan S, Karube K, Ohshima K, Muta K, Nawata H, Morishima Y, Nakamura S, Seto M: Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK/T-cell lymphoma, nasal type. Genes Chromosomes Cancer 2005, 44(3): 247-255. 10. 1002/gcc. 20245.
24. Yagita M, Huang CL, Umehara H, Matsuo Y, Tabata R, Miyake M, Konaka Y, Takatsuki K: A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia 2000, 14: 922-930. 10. 1038/sj. leu. 2401769.
25. Liang R, Lau GK, Kwong YL: Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem. J Clin Oncol 1999, 17(1): 394-398.
26. +T-cell immunity proceedings of the National Academy of Science of the United States of America. PNAS 2012, 109(4): 1210-1215. 10. 1073/pnas. 1118834109.
27. Kato K, Ohshima K, Ishihara S, Anzai K, Suzumiya J, Kikuchi M: Elevated serum soluble Fas ligand in natural killer cell proliferative disorders. Br J Haematol 1998, 103: 1164-1166. 10. 1046/j. 1365-2141. 1998. 01095. x.
28. Makishima H, Ito T, Momose K, Nakazawa H, Shimodaira S, Kamijo Y, Nakazawa Y, Ichikawa N, Ueno M, Kobayashi H, Kitano K, Saito H, Kiyosawa K, Ishida F: Chemokine system and tissue infiltration in aggressive NK-cell leukaemia. Leukaemia Res 2007, 31: 1245-1253.
29. Palmqvist C, Wardlaw AJ, Bradding P: Chemokines and their receptors as potential targets for the treatment of asthma. Br J Pharmacol 2007, 151: 725-736. doi: 10. 1038/sj. bjp. 0707263.